After nearly a decade of machine learning innovations, the FDA has issued its first draft guidance on the use of AI in drug ...
Rigel Pharmaceuticals on Thursday said the U.S. Food and Drug Administration granted orphan-drug designation to its proposed R289 treatment for myelodysplastic syndromes, a group of rare blood cancers ...
The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...
The biotherapeutics company said the treatment, LYT-200, is being evaluated in two ongoing clinical trials. It was previously granted orphan drug designation for the treatment of acute myeloid ...
With multiple stakeholders involved with different interests, the “specialty drug” definition can be a moving target.
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...